Table 2.
Univariate and multivariate analysis of related risk factors of active IBD
| univariate | multivariate | ||||
|---|---|---|---|---|---|
| OR(95%CI) | P | OR(95%CI) | P | ||
| Sex | 0.546(0.225–1.325) | > 0.05 | |||
| Age | 0.999(0.971–1.028) | > 0.05 | |||
| BMI | 0.899(0.781–1.036) | > 0.05 | |||
| hsCRP | 1.287(1.083–1.529) | < 0.05 | 1.152(0.967–1.373) | > 0.05 | |
| TC | 0.513(0.197–1.333) | > 0.05 | |||
| TG | 1.274(0.806,2.013) | > 0.05 | |||
| LDL | 0.820(0.471–1.428) | > 0.05 | |||
| Hb | 0.974(0.950–0.999) | < 0.05 | 0.987(0.944–1.033) | > 0.05 | |
| serum | IFN-γ | 1.176(1.038–1.333) | < 0.05 | 1.145(0.959–1.369) | > 0.05 |
| CXCL9 | 1.004(1.001–1.007) | < 0.05 | 1.002(0.998–1.006) | > 0.05 | |
| PDGF-BB | 1.010(1.003–1.016) | < 0.05 | 1.009(1.000-1.018) | > 0.05 | |
|
colonic mucosa |
CD86 | 1.319(1.066–1.631) | < 0.05 | 1.345(1.005–1.799) | < 0.05 |
| CXCL9 | 1.366(1.103–1.691) | < 0.05 | 1.342(0.995–1.810) | > 0.05 | |
| PDGF-BB | 1.761(1.249–2.482) | < 0.05 | 1.643(1.005–2.688) | < 0.05 | |